Literature DB >> 24627122

Bone union rate with recombinant human bone morphogenic protein-2 versus autologous iliac bone in PEEK cages for anterior lumbar interbody fusion.

Charles-Henri Flouzat-Lachaniette1, Amir Ghazanfari, Charlie Bouthors, Alexandre Poignard, Philippe Hernigou, Jérôme Allain.   

Abstract

PURPOSE: Autologous iliac crest bone graft (ICBG) is the gold standard material for spinal fusion. Bone graft substitutes, such as recombinant human bone morphogenic protein 2 (rhBMP-2) have been developed to promote spinal fusion and address morbidity issues related to ICBG harvesting. The objective of this study was to compare bone fusion rates after anterior lumbar interbody fusion (ALIF) between ICBG and rhBMP-2 by examining thin-cut computed tomography (CT) images at the one year follow-up.
METHODS: Fifty one patients (62 levels) who underwent single- or two-level ALIF via the video-assisted minimally invasive anterior approach in our institution were assessed. Radiolucent cages were inserted in all cases. Each cage has a middle beam delimiting two chambers. Grafting was performed as follows: one chamber was filled with autologous ICBG, and the other chamber was filled with 6 mg of rhBMP-2. Thin-cut CT-scan multiplanar reconstruction analyses were performed to assess the rate and quality of bone fusion at one year of follow-up.
RESULTS: Fusion was observed in 55 levels (88.7 %), with significant differences in fusion rates with rhBMP-2 and ICBG (71 % vs. 88.7 %) (P=0.001). Osteogenesis in the rhBMP-2 chamber had a centripetal pattern in all cases, leaving a central void in 97.7 % of cases representing 38.3 % of the surface of its chamber (range 0-80.3 %). In ICBG chambers, graft resorption was present in 44.4 %, representing 9.8 % of the chamber surface (range 0-52.2 %).
CONCLUSION: RhBMP-2 was inferior to ICBG in terms of rate and quality of bone fusion in one- or two-level ALIF.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24627122     DOI: 10.1007/s00264-014-2301-6

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  23 in total

Review 1.  Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications.

Authors:  Bill McKay; Harvinder S Sandhu
Journal:  Spine (Phila Pa 1976)       Date:  2002-08-15       Impact factor: 3.468

2.  The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report.

Authors:  S D Boden; T A Zdeblick; H S Sandhu; S E Heim
Journal:  Spine (Phila Pa 1976)       Date:  2000-02-01       Impact factor: 3.468

3.  Lumbar interbody fusion using the Brantigan I/F cage for posterior lumbar interbody fusion and the variable pedicle screw placement system: two-year results from a Food and Drug Administration investigational device exemption clinical trial.

Authors:  J W Brantigan; A D Steffee; M L Lewis; L M Quinn; J M Persenaire
Journal:  Spine (Phila Pa 1976)       Date:  2000-06-01       Impact factor: 3.468

4.  Off-label use of bone morphogenetic proteins in the United States using administrative data.

Authors:  Kevin L Ong; Marta L Villarraga; Edmund Lau; Leah Y Carreon; Steven M Kurtz; Steven D Glassman
Journal:  Spine (Phila Pa 1976)       Date:  2010-09-01       Impact factor: 3.468

5.  Iliac crest bone graft donor site pain after anterior lumbar interbody fusion: a prospective patient satisfaction outcome assessment.

Authors:  Rick C Sasso; Jean Charles LeHuec; Christopher Shaffrey
Journal:  J Spinal Disord Tech       Date:  2005-02

6.  Influence of rhBMP-2 on the healing patterns associated with allograft interbody constructs in comparison with autograft.

Authors:  J Kenneth Burkus; Harvinder S Sandhu; Matthew F Gornet
Journal:  Spine (Phila Pa 1976)       Date:  2006-04-01       Impact factor: 3.468

Review 7.  Safety profile for the clinical use of bone morphogenetic proteins in the spine.

Authors:  Ashley R Poynton; Joseph M Lane
Journal:  Spine (Phila Pa 1976)       Date:  2002-08-15       Impact factor: 3.468

8.  Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data.

Authors:  Mark C Simmonds; Jennifer V E Brown; Morag K Heirs; Julian P T Higgins; Richard J Mannion; Mark A Rodgers; Lesley A Stewart
Journal:  Ann Intern Med       Date:  2013-06-18       Impact factor: 25.391

9.  Donor site pain from the ilium. A complication of lumbar spine fusion.

Authors:  B N Summers; S M Eisenstein
Journal:  J Bone Joint Surg Br       Date:  1989-08

10.  A prospective, randomized, blinded, single-site study to evaluate the clinical and radiographic differences between frozen and freeze-dried allograft when used as part of a circumferential anterior lumbar interbody fusion procedure.

Authors:  John S Thalgott; Madilyne E Fogarty; James M Giuffre; Stephani D Christenson; Alexandra K Epstein; Charles Aprill
Journal:  Spine (Phila Pa 1976)       Date:  2009-05-20       Impact factor: 3.468

View more
  8 in total

1.  Trends analysis of rhBMP utilization in single-level posterior lumbar fusion (PLF) in the United States.

Authors:  Lifeng Lao; Jeremiah R Cohen; Elizabeth L Lord; Zorica Buser; Jeffrey C Wang
Journal:  Eur Spine J       Date:  2015-05-24       Impact factor: 3.134

2.  Bone substitutes and expanders in Spine Surgery: A review of their fusion efficacies.

Authors:  Abhijeet Kadam; Paul W Millhouse; Christopher K Kepler; Kris E Radcliff; Michael G Fehlings; Michael E Janssen; Rick C Sasso; James J Benedict; Alexander R Vaccaro
Journal:  Int J Spine Surg       Date:  2016-09-22

3.  Marshall R. Urist and the discovery of bone morphogenetic proteins.

Authors:  Lovorka Grgurevic; Marko Pecina; Slobodan Vukicevic
Journal:  Int Orthop       Date:  2017-02-11       Impact factor: 3.075

4.  Tissue engineering and regenerative orthopaedics (TERO).

Authors:  Marko Pećina; Slobodan Vukičević
Journal:  Int Orthop       Date:  2014-08-12       Impact factor: 3.075

5.  The Influences of Different Ratios of Biphasic Calcium Phosphate and Collagen Augmentation on Posterior Lumbar Spinal Fusion in Rat Model.

Authors:  Kyung Hyun Kim; Jeong Yoon Park; Hyo Suk Park; Keun Su Kim; Dong Kyu Chin; Yong Eun Cho; Sung Uk Kuh
Journal:  Yonsei Med J       Date:  2017-03       Impact factor: 2.759

Review 6.  Supramolecular self-assembling peptides to deliver bone morphogenetic proteins for skeletal regeneration.

Authors:  Charlotte H Chen; Erin L Hsu; Samuel I Stupp
Journal:  Bone       Date:  2020-07-31       Impact factor: 4.398

7.  Comparison of the PEEK cage and an autologous cage made from the lumbar spinous process and laminae in posterior lumbar interbody fusion.

Authors:  Bin Lin; Hui Yu; Zhida Chen; Zhuanzhi Huang; Wenbin Zhang
Journal:  BMC Musculoskelet Disord       Date:  2016-08-30       Impact factor: 2.362

8.  Characterization of Naturally Occurring Bioactive Factor Mixtures for Bone Regeneration.

Authors:  Henriette Bretschneider; Mandy Quade; Anja Lode; Michael Gelinsky; Stefan Rammelt; Stefan Zwingenberger; Klaus-Dieter Schaser; Corina Vater
Journal:  Int J Mol Sci       Date:  2020-02-19       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.